Biology Reference
In-Depth Information
Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG (2005) An
Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and
behavior. Cell 122:261-273
Bergman M, Mustelin T, Oetken C, Partanen J, Flint NA, Amrein KE, Autero M, Burn P, Alitalo K
(1992) The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down
regulates its catalytic activity. EMBO J 11:2919-2924
Beyer M, Schultze JL (2006) Regulatory T cells in cancer. Blood 108:804-811
Bjorgo E, Solheim SA, Abrahamsen H, Baillie GS, Brown KM, Berge T, Okkenhaug K, Houslay
MD, Tasken K (2010) Crosstalk between PI3-Kinase and cAMP-protein kinase A signaling
pathways at the level of a Protein Kinase B/{beta}-arrestin/cAMP phosphodiesterase-4 com-
plex. Mol Cell Biol 30:1660-1672
Bloom TJ, Beavo JA (1996) Identification and tissue-specific expression of PDE7 phosphodies-
terase splice variants. Proc Natl Acad Sci USA 93:14188-14192
Bluestone JA, Abbas AK (2003) Natural versus adaptive regulatory T cells. Nat Rev Immunol
3:253-257
Bolger GB, McCahill A, Huston E, Cheung YF, McSorley T, Baillie GS, Houslay MD (2003)
The unique amino-terminal region of the PDE4D5 cAMP phosphodiesterase isoform confers
preferential interaction with beta-arrestins. J Biol Chem 278:49230-49238
Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Heib V, Becker M,
Kubach J, Schmitt S, Stoll S, Schild H, Staege MS, Stassen M, Jonuleit H, Schmitt E (2007)
Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppres-
sion. J Exp Med 204:1303-1310
Brdicka T, Pavlistova D, Leo A, Bruyns E, Korinek V, Angelisova P, Scherer J, Shevchenko A,
Hilgert I, Cerny J, Drbal K, Kuramitsu Y, Kornacker B, Horejsi V, Schraven B (2000)
Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel
ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk
and is involved in regulation of T cell activation. J Exp Med 191:1591-1604
Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ (2009) Roflumilast
in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet
374:685-694
Conti M, Beavo J (2007) Biochemistry and physiology of cyclic nucleotide phosphodiesterases:
essential components in cyclic nucleotide signaling. Annu Rev Biochem 76:481-511
Conti M, Jin SL (1999) The molecular biology of cyclic nucleotide phosphodiesterases. Prog
Nucleic Acid Res Mol Biol 63:1-38
Corbin JD, Francis SH, Webb DJ (2002) Phosphodiesterase type 5 as a pharmacologic target in
erectile dysfunction. Urology 60:4-11
Davidson D, Bakinowski M, Thomas ML, Horejsi V, Veillette A (2003) Phosphorylation-dependent
regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor.
Mol Cell Biol 23:2017-2028
de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL (1998)
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature
396:474-477
Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J,
Oukka M, Kuchroo VK, Strom TB, Robson SC (2007) Adenosine generation catalyzed by
CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med
204:1257-1265
DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) Beta-arrestins and cell signaling. Annu Rev
Physiol 69:483-510
Diehn M, Alizadeh AA, Rando OJ, Liu CL, Stankunas K, Botstein D, Crabtree GR, Brown PO
(2002) Genomic expression programs and the integration of the CD28 costimulatory signal in
T cell activation. Proc Natl Acad Sci USA 99:11796-11801
Erdogan S, Houslay MD (1997) Challenge of human Jurkat T-cells with the adenylate cyclase
activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by
